VAXX
Vaxxinity Inc - Ordinary Shares - Class A

1,141
Mkt Cap
$42,198.00
Volume
273,395.00
52W High
$0.06
52W Low
$0.00
Price
$0.0003
VAXX Fundamentals
Prev Close
$0.0003
Open
$0.0003
50D MA
$0.0051
Beta
-2,332.58
Avg. Volume
24,171.11
Loading...
Loading...
Vaxxinity, Inc. is a biotechnology company that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. The company uses its synthetic peptide vaccine platform to harness the immune system and convert the body into its own 'drug factory', stimulating the production of antibodies with a therapeutic effect. Its current pipeline consists of five chronic disease candidates from early to late-stage development across multiple therapeutic areas including Alzheimer’s, Parkinson’s, migraine and hypercholesterolemia as well as a candidate for COVID-19 prevention. The company was founded by Louis G. Reese IV and Mei Mei Hu in 2014 and is headquartered in Exploration Park, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Vaxxinity Inc - Ordinary Shares - Class A?
What is the 52-week high for Vaxxinity Inc - Ordinary Shares - Class A?
What is the 52-week low for Vaxxinity Inc - Ordinary Shares - Class A?
What is Vaxxinity Inc - Ordinary Shares - Class A stock price today?
What was Vaxxinity Inc - Ordinary Shares - Class A stock price yesterday?
What is the 50-day moving average of Vaxxinity Inc - Ordinary Shares - Class A?

Latest VAXX News

View
No VAXX news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.